Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
出版年份 2020 全文链接
标题
Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
作者
关键词
-
出版物
Nature Communications
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-07-29
DOI
10.1038/s41467-020-17552-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting the niche: depleting haemopoietic stem cells with targeted therapy
- (2019) Edward Abadir et al. BONE MARROW TRANSPLANTATION
- Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia
- (2019) Sarah Marktel et al. NATURE MEDICINE
- CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
- (2019) Grégoire Cullot et al. Nature Communications
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response
- (2019) Giulia Schiroli et al. Cell Stem Cell
- Editing the Sickle Cell Disease Mutation in Primary Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates
- (2019) Zulema Romero et al. MOLECULAR THERAPY
- Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain
- (2018) Berendine J Ebbink et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency
- (2018) Valentina Poletti et al. Molecular Therapy-Methods & Clinical Development
- A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
- (2018) Christopher A. Vakulskas et al. NATURE MEDICINE
- Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements
- (2018) Annalisa Lattanzi et al. MOLECULAR THERAPY
- Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing
- (2017) Jianguo Wen et al. Journal of Hematology & Oncology
- Neural stem cells for disease modeling of Wolman disease and evaluation of therapeutics
- (2017) Francis Aguisanda et al. Orphanet Journal of Rare Diseases
- Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease
- (2017) Novalia Pishesha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complexity of immune responses to AAV transgene products – Example of factor IX
- (2017) Roland W. Herzog CELLULAR IMMUNOLOGY
- Blood–brain barrier shuttle peptides: an emerging paradigm for brain delivery
- (2016) Benjamí Oller-Salvia et al. CHEMICAL SOCIETY REVIEWS
- New agents in HSC mobilization
- (2016) Mélanie J. Domingues et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver
- (2016) Igor Theurl et al. NATURE MEDICINE
- In vivo genome editing of the albumin locus as a platform for protein replacement therapy
- (2015) R. Sharma et al. BLOOD
- Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9
- (2015) Chul-Yong Park et al. Cell Stem Cell
- BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
- (2015) Matthew C. Canver et al. NATURE
- Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
- (2015) Jianbin Wang et al. NATURE BIOTECHNOLOGY
- Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors
- (2015) Xiaoling Wang et al. NATURE BIOTECHNOLOGY
- Improved methods of AAV-mediated gene targeting for human cell lines using ribosome-skipping 2A peptide
- (2015) Sivasundaram Karnan et al. NUCLEIC ACIDS RESEARCH
- Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens
- (2015) Alizée J. Grimm et al. Scientific Reports
- Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins
- (2015) Séverine Ménoret et al. Scientific Reports
- Hepatitis B virus infection enhances susceptibility toward adeno-associated viral vector transductionin vitroandin vivo
- (2014) Marianna Hösel et al. HEPATOLOGY
- Promoterless gene targeting without nucleases ameliorates haemophilia B in mice
- (2014) A. Barzel et al. NATURE
- Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector
- (2014) Ami M. Kabadi et al. NUCLEIC ACIDS RESEARCH
- Easy quantitative assessment of genome editing by sequence trace decomposition
- (2014) Eva K. Brinkman et al. NUCLEIC ACIDS RESEARCH
- COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites
- (2014) Thomas J Cradick et al. Molecular Therapy-Nucleic Acids
- Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia A mice transplanted with genetically manipulated human cord blood stem cells
- (2013) Q. Shi et al. BLOOD
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
- (2013) F. Ann Ran et al. CELL
- Platelet Gene Therapy by Lentiviral Gene Delivery to Hematopoietic Stem Cells Restores Hemostasis and Induces Humoral Immune Tolerance in FIXnull Mice
- (2013) Yingyu Chen et al. MOLECULAR THERAPY
- Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood Cells
- (2013) Ryo Kurita et al. PLoS One
- Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier
- (2013) D. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
- (2013) A. Biffi et al. SCIENCE
- Protein Replacement Therapies for Rare Diseases: A Breeze for Regulatory Approval?
- (2013) J. A. Gorzelany et al. Science Translational Medicine
- Clinical Manifestations of -Thalassemia
- (2013) E. P. Vichinsky Cold Spring Harbor Perspectives in Medicine
- Erythropoiesis: Development and Differentiation
- (2013) E. Dzierzak et al. Cold Spring Harbor Perspectives in Medicine
- A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2
- (2012) John Hamilton et al. CLINICA CHIMICA ACTA
- The β-Globin Locus Control Region in Combination With the EF1α Short Promoter Allows Enhanced Lentiviral Vector-mediated Erythroid Gene Expression With Conserved Multilineage Activity
- (2012) Claudia A Montiel-Equihua et al. MOLECULAR THERAPY
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Engineering antigens for in situ erythrocyte binding induces T-cell deletion
- (2012) S. Kontos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophages prevent human red blood cell reconstitution in immunodeficient mice
- (2011) Z. Hu et al. BLOOD
- AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers
- (2011) L Sobrevals et al. GENE THERAPY
- In vivo genome editing restores haemostasis in a mouse model of haemophilia
- (2011) Hojun Li et al. NATURE
- An unbiased genome-wide analysis of zinc-finger nuclease specificity
- (2011) Richard Gabriel et al. NATURE BIOTECHNOLOGY
- High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice
- (2011) Jin Hee Kim et al. PLoS One
- Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A mice
- (2011) Ali Ramezani et al. THROMBOSIS AND HAEMOSTASIS
- Comparison of human cord blood engraftment between immunocompromised mouse strains
- (2010) S. P. McDermott et al. BLOOD
- Production, Purification and Characterization of Adeno-Associated Vectors
- (2010) Eduard Ayuso et al. CURRENT GENE THERAPY
- Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
- (2010) Sylvie Boutin et al. HUMAN GENE THERAPY
- Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors
- (2009) Gary C. Pien et al. JOURNAL OF CLINICAL INVESTIGATION
- X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua)
- (2009) Paolo Simioni et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reprogramming erythroid cells for lysosomal enzyme production leads to visceral and CNS cross-correction in mice with Hurler syndrome
- (2009) D. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
- (2009) N. Cartier et al. SCIENCE
- Sorting of lysosomal proteins
- (2008) Thomas Braulke et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Erythroid-specific Human Factor IX Delivery From In Vivo Selected Hematopoietic Stem Cells Following Nonmyeloablative Conditioning in Hemophilia B Mice
- (2008) Alex H Chang et al. MOLECULAR THERAPY
- Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment
- (2008) Jinhai Wang et al. NATURE BIOTECHNOLOGY
- In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of -thalassemia
- (2008) A. Miccio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now